Skip to main content
. Author manuscript; available in PMC: 2017 Sep 27.
Published in final edited form as: Lancet Infect Dis. 2015 Dec 23;16(3):331–338. doi: 10.1016/S1473-3099(15)00489-2

Table 2.

Ebola virus disease sequelae at first convalescent clinic visit in 277 survivors.

Number of survivors (%)
Arthralgias (symptom onset during ETU or after discharge) 210 (76%)
Any auditory symptoms (tinnitus, aural fullness, hearing loss) that started during ETU or after discharge 67 (24%)
Ocular symptoms (onset during ETU or after discharge) 167 (60%)
 Blurry vision 104 (38%)
 Light sensitivity 86 (31%)
 Itchy eye 86 (31%)
 Tearing 79 (29%)
 Pain 72 (26%)
 Foreign body sensation 68 (25%)
 Floaters 46 (17%)
 Redness 46 (17%)
 Flashes of light 43 (16%)
 Dry eye 39 (14%)
 Burning sensation 29 (11%)
 Loss of vision 7 (3%)
Uveitis diagnosed on slit-lamp and dilated fundoscopic examination* (68 eyes involved among 50 patients) 50 (18%)
 Anterior uveitis 31 (46%)
 Posterior uveitis 18 (26%)
 Intermediate uveitis 2 (3%)
 Panuveitis 17 (25%)

ETU = Ebola treatment unit.

*

A patient could have >1 type of uveitis if both eyes were involved.